These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1080 related articles for article (PubMed ID: 33296217)

  • 1. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy.
    Chen Z; Wang W; Li Y; Wei C; Zhong P; He D; Liu H; Wang P; Huang Z; Zhu W; Zhou Y; Qin L
    Mol Pharm; 2021 Jan; 18(1):386-402. PubMed ID: 33296217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
    Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
    Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
    Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistage delivery of CDs-DOX/ICG-loaded liposome for highly penetration and effective chemo-photothermal combination therapy.
    Xue X; Fang T; Yin L; Jiang J; He Y; Dai Y; Wang D
    Drug Deliv; 2018 Nov; 25(1):1826-1839. PubMed ID: 30458644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
    Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
    Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity.
    Shubhra QTH; Guo K; Liu Y; Razzak M; Serajum Manir M; Moshiul Alam AKM
    Acta Biomater; 2021 Sep; 131():493-507. PubMed ID: 34139367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Triggered Conformational Change of Antp-Based Drug Delivery Platform for Tumor Treatment with Combined Photothermal Therapy and Chemotherapy.
    Liang P; Wang M; Zhang S; Wang J; Dai C; Quan C
    Adv Healthc Mater; 2019 Aug; 8(15):e1900306. PubMed ID: 31211520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy.
    Yu J; Wang L; Xie X; Zhu W; Lei Z; Lv L; Yu H; Xu J; Ren J
    Int J Nanomedicine; 2023; 18():323-337. PubMed ID: 36700147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIR/pH-triggered aptamer-functionalized DNA origami nanovehicle for imaging-guided chemo-phototherapy.
    Li M; Yang G; Zheng Y; Lv J; Zhou W; Zhang H; You F; Wu C; Yang H; Liu Y
    J Nanobiotechnology; 2023 Jun; 21(1):186. PubMed ID: 37301952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated WS
    Long Y; Wu X; Li Z; Fan J; Hu X; Liu B
    Biomater Sci; 2020 Sep; 8(18):5088-5105. PubMed ID: 32812542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
    Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
    J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ligand modified erythrocyte coated polydopamine nanomedicine to codeliver chemotherapeutic agent and oxygen for chemo-photothermal synergistic cancer therapy.
    Zhang L; Huang P; Huang S; Wang T; Chen S; Chen Z; Zhou Y; Qin L
    Int J Pharm; 2022 Oct; 626():122156. PubMed ID: 36058410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.